Heterogeneity of genomic evolution and mutational profiles in multiple myeloma
Niccolò Bolli(University of Milan), Nikhil C. Munshi(Dana-Farber Cancer Institute), Yu‐Tzu Tai(Harvard University), Iñigo Martincorena(Wellcome Sanger Institute), Thierry Façon(Université de Lille), Michel Attal(Université Fédérale de Toulouse Midi-Pyrénées), Peter J. Campbell(Wellcome Sanger Institute), Kenneth C. Anderson(Dana-Farber Cancer Institute), Florence Magrangeas(Centre National de la Recherche Scientifique), Paul G. Richardson(Harvard University), Giovanni Parmigiani(Harvard University Press), José M. C. Tubío(Wellcome Sanger Institute), Élizabeth Anderson(Wellcome Sanger Institute), Laura Mudie(Wellcome Sanger Institute), Mariateresa Fulciniti(Dana-Farber Cancer Institute), Masood A. Shammas(Dana-Farber Cancer Institute), Hervé Avet‐Loiseau(Institut universitaire du cancer de Toulouse Oncopole), Graham R. Bignell(Lund University), Naim U. Rashid(Dana-Farber Cancer Institute), P. Andrew Futreal(Wellcome Sanger Institute), Serena Nik‐Zainal(University of Cambridge), Stéphane Minvielle(Centre National de la Recherche Scientifique), Adam S. Sperling(Dana-Farber Cancer Institute), Peter Van Loo(Wellcome Sanger Institute), Ludmil B. Alexandrov(UC San Diego Health System), Francesco Iorio(Human Technopole), Jonathan Hinton(Wellcome Sanger Institute), Yilong Li(Guizhou Academy of Agricultural Sciences), Philippe Moreau(Centre National de la Recherche Scientifique), Stuart McLaren(European Bioinformatics Institute), Jon W. Teague(Wellcome Sanger Institute), Kevin J. Dawson(Wellcome Sanger Institute), David C. Wedge(University of Manchester), Adam P. Butler(Wellcome Sanger Institute), Sarah O' Meara(Wellcome Sanger Institute)
Cited by 906
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
COSMIC: the Catalogue Of Somatic Mutations In Cancer
|Nucleic Acids Research|2018|5.2k
Drug repurposing: progress, challenges and recommendations
|Nature Reviews Drug Discovery|2018|4.6k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k